These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18041538)

  • 1. [Predictive capacity, comparison and clinic consequences of the Framingham-Wilson and REGICOR tables in persons for whom care has been provided at a health care center, Badajoz, Spain].
    Cañón Barroso L; Díaz Herrera N; Cruces Muro E; Nieto Hernández T; Garrote Florencio T; Buitrago F
    Rev Esp Salud Publica; 2007; 81(4):353-64. PubMed ID: 18041538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Original and REGICOR Framingham functions in a nondiabetic population of a Spanish health care center: a validation study.
    Buitrago F; Calvo-Hueros JI; Cañón-Barroso L; Pozuelos-Estrada G; Molina-Martínez L; Espigares-Arroyo M; Galán-González JA; Lillo-Bravo FJ
    Ann Fam Med; 2011; 9(5):431-8. PubMed ID: 21911762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Validation of 3 equations of coronary risk in diabetic population of a primary care center].
    Cañón-Barroso L; Cruces-Muro E; Fernández-Ochoa G; Nieto-Hernández T; García-Vellido A; Buitrago F
    Med Clin (Barc); 2006 Apr; 126(13):485-90. PubMed ID: 16624226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of the SCORE and REGICOR models for calculating cardiovascular risk in cardiovascular disease-free individuals at a healthcare center in Barcelona, Spain].
    Baena Díez JM; del Val Garcia JL; Héctor Salas Gaetgens L; Sánchez Pérez R; Altes Vaques E; Deixens Martínez B; Amatller Corominas M; Katia Núñez Casillas D
    Rev Esp Salud Publica; 2005; 79(4):453-64. PubMed ID: 16465962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of the SCORE function chart and the Framingham-REGICOR equation to estimate the cardiovascular risk in an urban population after 10 years of follow-up].
    Buitrago Ramírez F; Cañón Barroso L; Díaz Herrera N; Cruces Muro E; Bravo Simón B; Pérez Sánchez I
    Med Clin (Barc); 2006 Sep; 127(10):368-73. PubMed ID: 16987481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of population coronary heart disease risk estimated by the Framingham original and REGICOR calibrated functions].
    Ramos R; Solanas P; Cordón F; Rohlfs I; Elosua R; Sala J; Masiá R; Faixedas MT; Marrugat J
    Med Clin (Barc); 2003 Oct; 121(14):521-6. PubMed ID: 14599406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The REGICOR-calibrated function provides a better classification of high-risk patients on statin treatment in the Spanish population than the Framingham or SCORE classifications.
    Baena-Díez JM; Grau M; Sánchez-Pérez R; Altes-Vaques E; Salas-Gaetjens LH; Hernández-Ibáñez MR
    Rev Esp Cardiol; 2009 Oct; 62(10):1134-40. PubMed ID: 19793519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk and validation of cardiovascular risk prediction functions in a cohort of patients with type 2 diabetes followed for 10 years in Badajoz (SPAIN). AN observational study.
    Calvo-Hueros JI; Cañón-Barroso L; Morales-Gabardino JA; Buitrago F
    Prim Care Diabetes; 2021 Feb; 15(1):115-120. PubMed ID: 32811775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of coronary risk estimates derived using the Framingham and REGICOR equations].
    Cristóbal J; Lago F; de la Fuente J; González-Juanatey JR; Vázquez-Bellés P; Vila M
    Rev Esp Cardiol; 2005 Aug; 58(8):910-5. PubMed ID: 16053824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Incidence of cardiovascular disease and validity of equations of coronary risk in diabetic patients with metabolic syndrome].
    Cañón Barroso L; Díaz Herrera N; Calvo Hueros JI; Cruces Muro E; Nieto Hernández T; Buitrago Ramírez F
    Med Clin (Barc); 2007 Apr; 128(14):529-35. PubMed ID: 17433206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of the REGICOR and SCORE function charts for classifying cardiovascular risk and for selecting patients for hypolipidemic or antihypertensive treatment].
    Buitrago F; Cañón-Barroso L; Díaz-Herrera N; Cruces-Muro E; Escobar-Fernández M; Serrano-Arias JM
    Rev Esp Cardiol; 2007 Feb; 60(2):139-47. PubMed ID: 17338879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Framingham function overestimates the risk of ischemic heart disease in HIV-infected patients from Barcelona.
    Herrera S; Guelar A; Sorlì L; Vila J; Molas E; Grau M; Marrugat J; Esteve E; Güerri-Fernández R; Montero M; Knobel H
    HIV Clin Trials; 2016 Jul; 17(4):131-9. PubMed ID: 27169692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of the Framingham and SCORE cardiovascular risk prediction functions in a non-diabetic population of a Spanish health care centre: a validation study.
    Barroso LC; Muro EC; Herrera ND; Ochoa GF; Hueros JI; Buitrago F
    Scand J Prim Health Care; 2010 Dec; 28(4):242-8. PubMed ID: 20873973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Agreement between REGICOR and SCORE scales in identifying high cardiovascular risk in the Spanish population].
    Gil-Guillén V; Orozco-Beltrán D; Maiques-Galán A; Aznar-Vicente J; Navarro J; Cea-Calvo L; Quirce-Andrés F; Redón J; Merino-Sánchez J
    Rev Esp Cardiol; 2007 Oct; 60(10):1042-50. PubMed ID: 17953925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Estimating cardiovascular risk in Spain using different algorithms].
    Comín E; Solanas P; Cabezas C; Subirana I; Ramos R; Gené-Badía J; Cordón F; Grau M; Cabré-Vila JJ; Marrugat J
    Rev Esp Cardiol; 2007 Jul; 60(7):693-702. PubMed ID: 17663853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of the Framingham-REGICOR equation in a primary care centre. Impact on primary prevention of cardiovascular diseases].
    Parrilla Valero F; Segura Benedicto A; Segú Tolsa JL
    Aten Primaria; 2006 Nov; 38(9):490-5. PubMed ID: 17194352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiovascular risk in patients with renal failure].
    Calvo Hueros JI; Cañón Barroso L; Gómez Jiménez C; Martín Hidalgo-Barquero MV; Espigares Arroyo M; Buitrago Ramírez F
    Med Clin (Barc); 2008 Jun; 131(2):41-6. PubMed ID: 18588827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adding low ankle brachial index to classical risk factors improves the prediction of major cardiovascular events. The REGICOR study.
    Velescu A; Clara A; Peñafiel J; Ramos R; Marti R; Grau M; Dégano IR; Marrugat J; Elosua R;
    Atherosclerosis; 2015 Aug; 241(2):357-63. PubMed ID: 26071658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Carotid intima-media thickness distribution according to the stratification of cardiovascular risk by means of Framingham-REGICOR and score function charts].
    Hermida-Ameijeiras Á; López-Paz JE; Riveiro-Cruz MA; Calvo-Gómez C
    Hipertens Riesgo Vasc; 2016; 33(2):51-7. PubMed ID: 26796100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome and vascular risk estimation in a Mediterranean non-diabetic population without cardiovascular disease.
    Jansen-Chaparro S; Mancera J; Cuende JI; Villalobos A; Baca AJ; Lopez-Carmona MD; Bernal-Lopez MR; Tinahones FJ; Gomez-Huelgas R
    Eur J Intern Med; 2012 Sep; 23(6):558-63. PubMed ID: 22863435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.